China's Hillhouse Capital runs hard at testing biz George Clinical

Chinese private equity investor Hillhouse Capital is making a serious run at Australian clinical research organisation George Clinical, in what could become an interesting test of relations between Australia and China.
Read More

What's Hot

Snap Health Acquires Leading Healthcare Service Provider Your Therapy Source

HIV treatment fell inexcusably behind due to COVID lockdown

Western Australia To Ban Anti-Gay Conversion Practices

China’s Hillhouse Capital runs hard at testing biz George Clinical

Eisai to Present Preclinical and Clinical Research on Eribulin at the 2022 San Antonio Breast Cancer Symposium

A new therapeutic target for the prevention of heart failure due to aortic stenosis

TPG’s Novotech closes in on European beachhead EastHORN Clinical

Mayo Clinic expands AI-driven biomarker diagnostics partnership

Snap Health Acquires Leading Healthcare Service Provider Your Therapy Source

HIV treatment fell inexcusably behind due to COVID lockdown

Western Australia To Ban Anti-Gay Conversion Practices

Martha Eddy Jentz has been Inducted into the Prestigious Marquis Who’s Who Biographical Registry

Bruce Springsteen and These Lost Years

China’s long-term future with Covid-19 will depend on accurate data

The NIH-led research response to COVID-19 | Science

EdTech and Smart Classrooms Market Size Is Projected to Reach US$ 127.77 Bn and Grow at CAGR 13.56% over Forecasts Period 2023-2030 : Key Players: Apple Inc., Blackboard

China Reports 50% Decrease in COVID-Related Deaths

COVID-19: Saskatoon and Regina’s wastewater virus levels remain on the rise

What's Hot

China’s Hillhouse Capital runs hard at testing biz George Clinical

Related Posts